Allgens Medical Valuation
| 688613 Stock | 19.54 0.63 3.12% |
At this time, the firm appears to be overvalued. Allgens Medical Tech shows a prevailing Real Value of USD15.1 per share. The current price of the firm is USD19.54. Our model approximates the value of Allgens Medical Tech from analyzing the firm fundamentals such as Return On Equity of 3.0E-4, current valuation of 1.73 B, and Profit Margin of 0.03 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.9231 | Enterprise Value 1.7 B | Enterprise Value Ebitda 343.2944 | Price Sales 13.8536 | Trailing PE 488.5 |
Overvalued
Today
Please note that Allgens Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Allgens Medical Tech is based on 3 months time horizon. Increasing Allgens Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Allgens Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Allgens Stock. However, Allgens Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.54 | Real 15.1 | Hype 19.13 |
The real value of Allgens Stock, also known as its intrinsic value, is the underlying worth of Allgens Medical Tech Company, which is reflected in its stock price. It is based on Allgens Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Allgens Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Allgens Medical Technology helps investors to forecast how Allgens stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Allgens Medical more accurately as focusing exclusively on Allgens Medical's fundamentals will not take into account other important factors: Allgens Medical Cash |
|
Allgens Medical Total Value Analysis
Allgens Medical Technology is presently forecasted to have takeover price of 1.73 B with market capitalization of 2.65 B, debt of 5.07 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Allgens Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.73 B | 2.65 B | 5.07 M |
Allgens Medical Investor Information
About 43.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.92. In the past many companies with similar price-to-book ratios have beat the market. Allgens Medical Tech last dividend was issued on the 9th of July 2024. Allgens Medical Technology is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 89.5 M | 51.7 M |
|
| |||||
| Operating Income | 31.2 M | 32.9 M |
|
|
Allgens Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Allgens Medical has an asset utilization ratio of 14.84 percent. This suggests that the Company is making USD0.15 for each dollar of assets. An increasing asset utilization means that Allgens Medical Technology is more efficient with each dollar of assets it utilizes for everyday operations.Allgens Medical Ownership Allocation
Allgens Medical holds a total of 135.55 Million outstanding shares. Allgens Medical Technology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Allgens Medical Profitability Analysis
The company reported the revenue of 226.48 M. Net Income was 54.23 M with profit before overhead, payroll, taxes, and interest of 204.53 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Allgens Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Allgens Medical and how it compares across the competition.
About Allgens Medical Valuation
The stock valuation mechanism determines Allgens Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Allgens Medical. We calculate exposure to Allgens Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Allgens Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 187.2 M | 167 M |
Allgens Medical Quarterly Retained Earnings |
|
Complementary Tools for Allgens Stock analysis
When running Allgens Medical's price analysis, check to measure Allgens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allgens Medical is operating at the current time. Most of Allgens Medical's value examination focuses on studying past and present price action to predict the probability of Allgens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allgens Medical's price. Additionally, you may evaluate how the addition of Allgens Medical to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |